Stockscreener 앱 받기
46.24
1.70%
-0.89
전일 마감가:
$47.13
열려 있는:
$46.02
하루 거래량:
15.45M
Relative Volume:
0.39
시가총액:
$10.07B
수익:
$1.78B
순이익/손실:
$164.40M
주가수익비율:
67.01
EPS:
0.69
순현금흐름:
$236.51M
1주 성능:
-10.80%
1개월 성능:
-8.18%
6개월 성능:
-23.38%
1년 성능:
+194.91%
1일 변동 폭
$45.34
$47.35
1주일 범위
$45.28
$52.10
52주 변동 폭
$13.47
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
명칭
Hims Hers Health Inc
전화
415-851-0195
주소
2269 CHESTNUT ST, SAN FRANCISCO
HIMS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
46.26 | 10.92B | 1.78B | 164.40M | 236.51M | 0.69 |
|
PG
Procter Gamble Co
|
154.69 | 364.03B | 84.28B | 16.07B | 14.05B | 6.51 |
|
UL
Unilever Plc Adr
|
61.05 | 153.09B | 64.99B | 6.71B | 6.53B | 2.4495 |
|
CL
Colgate Palmolive Co
|
85.09 | 69.78B | 20.00B | 3.05B | 3.37B | 3.56 |
|
KMB
Kimberly Clark Corp
|
133.29 | 44.73B | 18.88B | 2.38B | 2.10B | 7.26 |
|
KVUE
Kenvue Inc
|
21.18 | 41.66B | 15.14B | 1.42B | 1.63B | 0.74 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-23 | 다운그레이드 | Needham | Buy → Hold |
| 2025-06-04 | 재확인 | Needham | Buy |
| 2025-04-29 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-02-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2025-01-07 | 개시 | BTIG Research | Buy |
| 2024-12-17 | 개시 | Morgan Stanley | Overweight |
| 2024-11-14 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-08-22 | 개시 | Needham | Buy |
| 2024-08-09 | 다운그레이드 | Imperial Capital | Outperform → In-line |
| 2024-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-04-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-04-10 | 개시 | Canaccord Genuity | Buy |
| 2024-02-28 | 업그레이드 | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2023-12-07 | 개시 | Imperial Capital | In-line |
| 2023-07-28 | 개시 | TD Cowen | Outperform |
| 2023-04-11 | 개시 | Robert W. Baird | Neutral |
| 2023-02-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-11-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-08 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-07-15 | 개시 | SVB Leerink | Underperform |
| 2022-04-14 | 개시 | Guggenheim | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2022-03-10 | 개시 | Deutsche Bank | Hold |
| 2021-12-02 | 개시 | Jefferies | Hold |
| 2021-11-11 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 개시 | BofA Securities | Neutral |
| 2021-05-20 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 개시 | Truist | Hold |
| 2021-03-09 | 개시 | Credit Suisse | Neutral |
| 2021-03-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-02-17 | 개시 | Citigroup | Neutral |
| 2021-02-12 | 개시 | Piper Sandler | Neutral |
| 2021-02-08 | 개시 | Tigress Financial | Buy |
모두보기
Hims Hers Health Inc 주식(HIMS)의 최신 뉴스
Did You Lose Money on Hims & Hers Health, Inc. (HIMS)? Levi & Korsinsky Urges Investors to Act Before August 25, 2025 - ACCESS Newswire
Hims & Hers HIMS Slides on FTC Probe. What’s Next? - NAI500
Precigen, Twilio, Hims & Hers - TradingView
Levi & Korsinsky Notifies Shareholders of Hims & Hers Health, Inc.(HIMS) of a Class Action Lawsuit and an Upcoming Deadline - Morningstar
HIMS: Hims & Hers Shares Sink After FTC Probe Details Emerge - Yahoo Finance
Why Is Hims & Hers Stock Falling Friday?Hims & Hers Health (NYSE:HIMS) - Benzinga
Hims & Hers Faces Scrutiny Over Subscription Cancellations - Finimize
Hims & Hers Health Under FTC Probe for Cancellation Policies - MarketScreener
Hims & Hers Health Plunges 2.48% on $1.11 Billion Volume Ranking 67th Amid FTC Scrutiny Over Cancellation Hurdles - AInvest
GLP-1 Sector Under Scrutiny: Hims & Hers' Crisis and the Future of Investor Trust - AInvest
Hims & Hers Health under investigation by FTC over business practicesreport - Seeking Alpha
HIMS DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, - GlobeNewswire
FTC Probing Complaints About Hims’ Cancellation Practices - Bloomberg.com
US FTC investigating Hims & Hers over advertising and cancellation practices, Bloomberg News reports - Reuters
Levi & Korsinsky Notifies Hims & Hers Health, Inc. (HIMS) InvestorsLead Plaintiff Deadline on August 25, 2025 - The Globe and Mail
FTC Investigates Hims & Hers Over Subscription Cancellation Complaints - AInvest
US FTC Investigating Hims & Hers Over Advertising and Cancellation Practices, Bloomberg News Reports - US News Money
US FTC investigating Hims & Hers over advertisements and cancellation practices, Bloomberg News reports - MarketScreener
Shareholders of Hims & Hers Health, Inc. Should Contact - GlobeNewswire
Hims & Hers Health, Inc.: Please contact the Portnoy Law - GlobeNewswire
HIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
HIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
HIMS DEADLINE REMINDER: Important August 25, 2025 Deadline - GlobeNewswire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health - Morningstar
HIMS LAWSUIT ALERT: The Gross Law Firm Notifies Hims & Hers Health, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - PR Newswire
Zacks Investment Ideas feature highlights: IonQ, Hims and Hers, Eli Lilly and TransMedics - Yahoo Finance
Hims & Hers Health (NYSE:HIMS) Stock Price Down 2.2% on Insider Selling - Defense World
Investors in Hims & Hers Health, Inc. (HIMS): Protect Your RightsContact Levi & Korsinsky Before August 25, 2025 - ACCESS Newswire
HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - GlobeNewswire Inc.
Lost Money on Hims & Hers Health, Inc. (HIMS)? Join Class Action Before August 25, 2025Contact Levi & Korsinsky - Stockhouse
The Gross Law Firm Announces the Filing of a Securities - GlobeNewswire
Hedge Fund and Insider Trading News: George Soros, Dan Loeb, Lee Ainslie, Warren Buffett, Millennium Management, Discovery Capital Management, Sculptor Capital, Warner Bros Discovery Inc (WBD), Hims & Hers Health Inc (HIMS), and More - Insider Monkey
Hims & Hers (HIMS) Falls as Key Executives Dispose Shares - Insider Monkey
Hims & Hers Stock Plunges 21.3% in 3 Months: Time to Hold or Exit? - Yahoo Finance
HIMS 2-WEEK DEADLINE ALERT: HIMS Shares Decline Amid Lower - GlobeNewswire
SueWallSt Podcast Explains Class Action Against Hims & Hers Health, Inc. (HIMS) - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming DeadlinesHIMS - FinancialContent
The Top 5 Analyst Questions From Hims & Hers Health’s Q2 Earnings Call - Yahoo Finance
Hims & Hers Health (NYSE:HIMS) Trading Down 4.1% Following Insider Selling - Defense World
Levi & Korsinsky Urges Hims & Hers Health, Inc. (HIMS) Shareholders to Act Before Lead Plaintiff Deadline August 25, 2025 - ACCESS Newswire
HIMS Q2 Deep Dive: International Expansion and Product Shifts Define Next Growth Phase - uk.finance.yahoo.com
HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - GlobeNewswire Inc.
Hims CEO Reports $33 Million Sale in Largest Insider Trade - Bloomberg.com
Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today - Yahoo Finance
Hims & Hers CEO sells $33 million in stock after a massive rally - MarketWatch
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health - Morningstar
Why Is Hims & Hers Stock Falling Tuesday?Hims & Hers Health (NYSE:HIMS), Novo Nordisk (NYSE:NVO) - Benzinga
DEADLINE ALERT for RDDT, HIMS, IRBT, and CNC: The Law - GlobeNewswire
Hims & Hers Drives the Consumer-Centric Transformation in Digital Care - Yahoo Finance
Deadline Alert: Hims & Hers Health, Inc. (HIMS) Investors - GlobeNewswire
Hims & Hers Health CEO discloses sale of over $33M worth of company stock - MSN
Hims Hers Health Inc (HIMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.81%
0.68%
자본화:
|
볼륨(24시간):